New Guidelines Address Preexisting Diabetes and Pregnancy
The new joint clinical practice guidelines from two endocrine societies make conditional recommendations for preconception, pregnancy, labor, and delivery based on very limited data.
Related Articles
Incretins and the cardiovascular system: bridging digestion with metabolism
The mechanisms driving the cardiovascular and renal benefits of therapies targeting intestinal hormones in type 2 diabetes are still not fully understood. We propose that…
CATALYST shows mifepristone for hypercortisolism in type 2 diabetes reduces A1C, weight – ADA Meeting News
Vivian Fonseca, MD, and other investigators explained the results of the largest prospective study to date of hypercortisolism in difficult-to-treat diabetes and pharmacotherapy of hypercortisolism.
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
In adults with type 2 diabetes, retatrutide significantly improved total body fat mass reduction compared with placebo and dulaglutide. The proportion of lean mass loss…
Body composition during major incretin-based weight loss
We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide…
Clinicians Warn Medicaid May Push Them Out of Practice
Clinicians fear cuts to the Medicaid could jeopardize the financial viability of their practices and increase gaps in patient care.
You Are When You Eat: Microbiome Rhythm and Metabolic Health
Using new tech to observe real-time changes in microbial gut activity, researchers find eating in preferred circadian windows could benefit metabolic health.
The Endocrine Society
The latest news from the ENDO Annual Meeting, with physician perspective, researcher interviews and clinician insight on diabetes, thyroid and other endocrine disorders.
Creatine: Is the Supplement Ready for Clinical Use?
From sarcopenia to ALS, researchers are exploring creatine’s broader clinical potential — but more trials are needed to confirm its value.
Incretins and the cardiovascular system: bridging digestion with metabolism
The mechanisms driving the cardiovascular and renal benefits of therapies targeting intestinal hormones in type 2 diabetes are still not fully understood. We propose that…
Beyond a singular focus on GLP-1: why we need a new nomenclature now
The development of glucagon-like peptide-1 (GLP-1)-based therapies for type 2 diabetes and obesity illustrates a remarkable evolution in scientific understanding and therapeutic innovation.1 As the…